PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-18.72%
↓ 120% below average
Average (9y)
93.36%
Historical baseline
Range
High:634.23%
Low:-97.58%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -18.72% |
| 2023 | -5.67% |
| 2022 | 161.50% |
| 2021 | 42.02% |
| 2020 | 29.92% |
| 2019 | 634.23% |
| 2018 | -97.58% |
| 2017 | 38.22% |
| 2016 | 39.15% |
| 2015 | 110.53% |